Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide
- PMID: 21357660
- DOI: 10.1124/jpet.110.177584
Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide
Abstract
The elderly are prone to postprandial hyperglycemia that increases their cardiovascular risk. Although insulin therapy is necessary to treat diabetes, high plasma concentrations of insulin may cause the development of atherosclerosis and accelerate endothelial senescence. We assumed that high glucose causes stress-induced premature senescence and replicative senescence and examined the regulatory role of insulin in endothelial senescence and functions under different glucose conditions. Exposure of human endothelial cells to high glucose (22 mM) for 3 days increased senescence-associated-β-galactosidase activity, a senescence marker, and decreased telomerase activity, a replicative senescence marker. Physiological concentrations of insulin preserved telomere length and delayed endothelial senescence under high-glucose conditions. The effect of insulin under high-glucose conditions was associated with reduced reactive oxygen species and increased nitric oxide (NO). Small interfering RNA targeting endothelial NO synthase reduced the antisenescence effects of insulin. Physiological concentrations of insulin also reversed high glucose-induced increases in p53 and vascular cell adhesion molecule-1 and decreases in senescence marker protein-30. On the other hand, when insulin was given at any concentrations under normal glucose or at high concentrations under high glucose, its ability to promote cellular senescence was unrelated to endothelial NO. Finally, streptozotocin-induced diabetes showed more senescent cells in the aortic endothelium of aged rats compared with age-matched control and insulin-treated animals. Conclusively, the regulatory effects of insulin on endothelial senescence were modulated by the glucose environment. These data may help explain insulin's complicated roles in atherosclerosis in the elderly.
Similar articles
-
Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.Circ Res. 2007 Feb 16;100(3):434-43. doi: 10.1161/01.RES.0000257912.78915.af. Epub 2007 Jan 18. Circ Res. 2007. PMID: 17234973
-
Effects of selaginellin on homocysteine-induced senescence in human umbilical vein endothelial cells.J Cardiovasc Pharmacol. 2010 Jun;55(6):560-6. doi: 10.1097/FJC.0b013e3181d9f478. J Cardiovasc Pharmacol. 2010. PMID: 20224429
-
Evidence against the involvement of nitric oxide in the modulation of telomerase activity or replicative capacity of human endothelial cells.Exp Gerontol. 2007 Sep;42(9):904-10. doi: 10.1016/j.exger.2007.01.007. Epub 2007 Feb 3. Exp Gerontol. 2007. PMID: 17339088
-
Nitric oxide and endothelial cellular senescence.Pharmacol Ther. 2008 Dec;120(3):333-9. doi: 10.1016/j.pharmthera.2008.09.002. Epub 2008 Sep 30. Pharmacol Ther. 2008. PMID: 18930078 Review.
-
Indoxyl sulfate induces nephrovascular senescence.J Ren Nutr. 2012 Jan;22(1):102-6. doi: 10.1053/j.jrn.2011.10.032. J Ren Nutr. 2012. PMID: 22200425 Review.
Cited by
-
Short-term high glucose exposure impairs insulin signaling in endothelial cells.Cardiovasc Diabetol. 2015 Aug 22;14:114. doi: 10.1186/s12933-015-0278-0. Cardiovasc Diabetol. 2015. PMID: 26297582 Free PMC article.
-
IGFBP7 is a key component of the senescence-associated secretory phenotype (SASP) that induces senescence in healthy cells by modulating the insulin, IGF, and activin A pathways.Cell Commun Signal. 2024 Nov 12;22(1):540. doi: 10.1186/s12964-024-01921-2. Cell Commun Signal. 2024. PMID: 39533382 Free PMC article.
-
Dapagliflozin impedes endothelial cell senescence by activating the SIRT1 signaling pathway in type 2 diabetes.Heliyon. 2023 Aug 21;9(8):e19152. doi: 10.1016/j.heliyon.2023.e19152. eCollection 2023 Aug. Heliyon. 2023. PMID: 37664712 Free PMC article.
-
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms.Cardiovasc Drugs Ther. 2021 Dec;35(6):1253-1267. doi: 10.1007/s10557-021-07216-9. Epub 2021 Jul 17. Cardiovasc Drugs Ther. 2021. PMID: 34273091 Review.
-
Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction.Biomed Res Int. 2014;2014:193095. doi: 10.1155/2014/193095. Epub 2014 Mar 5. Biomed Res Int. 2014. PMID: 24734227 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous